Gilead Sciences

In 2025, Gilead Sciences reported a revenue of $27.1 billion, representing a slight decline from the previous year. The company's net income was $5.665 billion, maintaining a strong profit margin of 20.9%.

• ·Revenue decreased by approximately 0.6% compared to the previous fiscal year.
• ·Net income stood at $5.665 billion.
• ·Profit margin remained robust at 20.9%.